Einloggen

Thematische Bibliographien / Diagnosis and monitoring of bladder cancer / Bücher

Um die anderen Arten von Veröffentlichungen zu diesem Thema anzuzeigen, folgen Sie diesem Link: Diagnosis and monitoring of bladder cancer.

Bücher zum Thema „Diagnosis and monitoring of bladder cancer“

Autor: Grafiati

Veröffentlicht am 29. März 2025

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit Top-50 Bücher für die Forschung zum Thema "Diagnosis and monitoring of bladder cancer" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Sehen Sie die Bücher für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.

1

J, Droller Michael, Hrsg. Bladder cancer: Current diagnosis and treatment. Totowa, N.J: Humana Press, 2001.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

2

Nilsson, William E. Bladder cancer: Etymology, diagnosis, and treatments. Hauppauge, N.Y: Nova Science Publishers, 2010.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

3

Lee, Cheryl T. Bladder cancer: Diagnosis, therapeutics, and management. New York, NY: Humana Press, 2010.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

4

N, Syrigos Konstantinos, und Skinner Donald G, Hrsg. Bladder cancer: Biology, diagnosis, and management. Oxford: Oxford University Press, 1999.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

5

A, Stoll Basil, Hrsg. Screening and monitoring of cancer. Chichester: Wiley, 1985.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

6

Hayat, M. A. Methods of Cancer Diagnosis, Therapy, and Prognosis: Ovarian Cancer, Renal Cancer, Urogenitary tract Cancer, Urinary Bladder Cancer, Cervical Uterine Cancer, Skin Cancer, Leukemia, Multiple Myeloma and Sarcoma. Dordrecht: Springer Science+Business Media B.V., 2010.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

7

G, Maldonado Jonathon, und Cervantes Mikayla K, Hrsg. Small cell carcinomas: Causes, diagnosis and treatment. Hauppauge, N.Y: Nova Science, 2009.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

8

Maldonado, Jonathon G. Small cell carcinomas: Causes, diagnosis and treatment. New York: Nova Biomedical Books, 2009.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

9

Galsky, Matthew D. Dx/Rx: Genitourinary oncology : cancer of the kidneys, bladders, and testis. 2. Aufl. Sudbury, Mass: Jones & Bartlett Learning, 2012.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

10

Giampietro, Gasparini, und Hayes Daniel 1951-, Hrsg. Biomarkers in breast cancer: Molecular diagnostics for predicting and monitoring therapeutic effect. Totowa, N.J: Humana Press, 2006.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

11

Maldonado, Jonathon G., und Mikayla K. Cervantes. Small cell carcinomas: Causes, diagnosis and treatment. New York: Nova Biomedical Books, 2009.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

12

Canada. Health Canada. Evaluation Indicators Working Group. Guidelines for monitoring breast screening program performance: Report from the Evaluation Indicators Working Group. 2. Aufl. [Ottawa]: Public Health Agency of Canada, 2007.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

13

Australian Institute of Health and Welfare. National Bowel Cancer Screening Program monitoring report, 2008: 7 August 2006-30 June 2008. Canberra: Australian Institute of Health and Welfare, 2007.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

14

Barentsz, Jelle O. Magnetic resonance imaging of carcinoma of the urinary bladder. Dordrecht: Kluwer Academic Publishers, 1990.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

15

Australia, BreastScreen. BreastScreen Australia monitoring report / the Australian Institute of Health Welfare and the Australian Government Department of Health and Aging for the BreastScreen Australia Program. Canberra: Australian Institute of Health and Welfare, c2003., 2003.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

16

Group, Canada Health Canada Evaluation Indicators Working. Report from the Evaluation Indicators Working Group: Guidelines for monitoring breast screening program performance. [Ottawa]: Health Canada, 2002.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

17

Canada. Health Canada. Evaluation Indicators Working Group. Report from the Evaluation Indicators Working Group: Guidelines for monitoring breast screening program performance. 2. Aufl. [Ottawa]: Public Health Agency of Canada, 2007.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

18

E, Matouschek, European Organization for Research on Treatment of Cancer. Genito-Urinary Tract Cancer Cooperative Group. und World Health Organization. Collaborating Centre for Urinary Bladder and Prostatic Cancer, Hrsg. Endourology: [proceedings of the Third Congress of the International Society of Urologic Endoscopy, together with World Health Organization (W.H.O.) Collaborating Centre for Urinary Bladder and Prostatic Cancer and with European Organization of Research on the Treatment of Cancer (E.O.R.T.C.) Genito-Urinary Tract Cancer Cooperative Group; August 26-30, 1984, Karlsruhe, Federal Republic of Germany]. Baden-Baden: BuA-Verlag Werner Steinbrück, 1985.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

19

Public Health Agency of Canada. Centre for Chronic Disease Prevention and Control und Agence de santé publique du Canada. Centre de prévention et de contrôle des maladies chroniques, Hrsg. Report from the evaluation indicators working group: Guidelines for monitoring breast screening program performance = Rapport du groupe de travail sur les indicateurs d'évaluation : lignes directrices pour la surveillance de la performance des programmes de dépistage du cancer du sein. 2. Aufl. [Ottawa, Ont.]: Public Health Agency of Canada = Agence de santé publique du Canada, 2007.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

20

Lee, Cheryl T., und David P. Wood. Bladder Cancer. Springer, 2011.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

21

Syrigos, Konstantinos, und Konstantinos N. Syrigos. Bladder Cancer: Biology, Diagnosis, Management. John Wiley & Sons Inc, 2001.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

22

Bladder Cancer: Diagnosis and Clinical Management. Wiley-Interscience, 2015.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

23

Bladder Cancer: Current Diagnosis and Treatment. Humana Press, 2012.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

24

Schoenberg, Mark P., Seth P. Lerner und Cora N. Sternberg. Bladder Cancer: Diagnosis and Clinical Management. Wiley & Sons, Incorporated, John, 2015.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

25

Droller, MD Michael J. Bladder Cancer: Current Diagnosis and Treatment. Humana, 2010.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

26

Schoenberg, Mark P., Seth P. Lerner und Cora N. Sternberg. Bladder Cancer: Diagnosis and Clinical Management. Wiley & Sons, Incorporated, John, 2015.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

27

Lee, Cheryl T., und David P. Wood. Bladder Cancer: Diagnosis, Therapeutics, and Management. Humana Press, 2012.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

28

Schoenberg, Mark P., Seth P. Lerner und Cora N. Sternberg. Bladder Cancer: Diagnosis and Clinical Management. Wiley & Sons, Limited, John, 2015.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

29

Silverman, Debra T., Stella Koutros, Jonine D. Figueroa, Ludmila Prokunina-Olsson und Nathaniel Rothman. Bladder Cancer. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0052.

Der volle Inhalt der Quelle

Annotation:

In the United States, an estimated 74,000 new cases of bladder cancer and 16,000 deaths occur annually. Because of favorable survival, approximately 578,000 persons are alive after diagnosis. Recurrence after treatment is common, necessitating lifelong surveillance and care, making bladder cancer the most costly malignancy from diagnosis to death. The median age at diagnosis has increased from 67 years in 1980 to 73 years in 2008–2012. Incidence rates rise dramatically with age, suggesting that as the US population ages, the burden of bladder cancer in the United States will continue to grow. Worldwide over 1.3 million cases are estimated to occur annually. Cigarette smoking is the principal known cause of bladder cancer, along with various chemical exposures. Recent studies suggest that, over the past two decades, the risk for current smokers has increased from three times the risk of nonsmokers to about four to five times the nonsmoker risk.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

30

(Editor), Konstantinos N. Syrigos, und Donald Skinner (Editor), Hrsg. Bladder Cancer: Biology, Diagnosis and Management (Oxford Medical Publications). Oxford University Press, USA, 1999.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

31

Teoh, Jeremy, und Daniele Castellani, Hrsg. Recent Advances in Bladder Cancer Diagnosis and Treatment. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-88976-080-0.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

32

Droller, Michael J. Bladder Cancer: Current Diagnosis and Treatment (Current Clinical Urology). Humana Press, 2001.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

33

Ziglioli, Francesco, und Umberto Maestroni. Modern Approach to Diagnosis and Treatment of Bladder Cancer. IntechOpen, 2021.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

34

Bladder Cancer: Diagnosis, Therapeutics, and Management (Current Clinical Urology). Humana Press, 2008.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

35

Bellmunt, Joaquim. Bladder Cancer, an Issue of Hematology/Oncology Clinics of North America. Elsevier, 2015.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

36

Chapman, Hannah, und Christine Elwell. Renal and bladder cancer. Herausgegeben von Patrick Davey und David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0167.

Der volle Inhalt der Quelle

Annotation:

This chapter addresses the diagnosis and management of bladder and renal cancers. In the UK, bladder cancer is the fourth most common cancer in men, and the eighth most common cancer in women. Bladder cancer arises from the bladder urothelium, and is typically a papillary transitional cell carcinoma. Chronic infection with the parasite Schistosoma haematobium is associated with squamous cell carcinoma of the bladder, and is most prevalent in Egypt and sub-Saharan Africa. Renal cancer accounts for 3% of cancers in adults in the UK and, in most cases, is a renal cell carcinoma arising from proximal renal tubule epithelium. A further 5%–10% of renal cancers are transitional cell (urothelial) carcinomas of the renal pelvis. Benign kidney tumours, such as cysts, are also common.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

37

Brinkman, Maree, und Maurice Zeegars. Screening for bladder cancer. Herausgegeben von James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0073.

Der volle Inhalt der Quelle

Annotation:

Bladder cancer (BC) is one of the most common urological malignancies and ranks ninth among all cancers worldwide. While screening has the potential to detect early cases of BC and reduce disease specific mortality, to date there are no routine screening programmes of asymptomatic individuals conducted anywhere in the world. There are however, a range of tests and procedures available for the detection and subsequent diagnosis of BC for select individuals presenting with urological symptoms and who are at increased risk of the disease.This chapter provides an overview of the traditional screening tools used for the detection of BC, such as urinalysis for haematuria and urinary cytology, as well as a brief description of follow-up procedures including cystoscopy, imaging, and treatment modalities.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

38

Bryant, Richard J., und James W. F. Catto. General overview of bladder cancer. Herausgegeben von James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0074.

Der volle Inhalt der Quelle

Annotation:

Bladder cancer (BC) is a common malignancy and is one of the most expensive to manage. This tumour typically affects middle-aged and elderly patients and is more common in men. These demographics reflect the aetiological links between BC and tobacco smoking and occupational exposure to carcinogens. While the presenting symptom of BC is usually painless visible haematuria, around one-quarter of tumours present with irritative voiding symptoms, recurrent or antibiotic-refractory urinary tract infections, non-visible haematuria, or are found by chance during the investigation of unrelated symptoms. As such, these urological symptoms require urgent investigation in patients at risk of BC. The diagnosis of BC is confirmed by endoscopic transurethral resection. This procedure requires meticulous tumour excision, sampling of the underlying detrusor muscle and the flat urothelium or prostatic urethra in patients with high-grade cancers. The prognosis of BC depends upon tumour grade, stage, and other features.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

39

Small cell carcinomas: Causes, diagnosis and treatment. New York: Nova Biomedical Books, 2009.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

40

Goossens, Maria E., Frank Buntinx und Maurice P. Zeegers. Bladder and upper urinary tract cancer. Herausgegeben von James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0070.

Der volle Inhalt der Quelle

Annotation:

Urinary bladder cancer (UBC) ranks ninth in worldwide cancer incidence. The most common histological type in Western countries is transitional cell carcinoma (TCC), while in Africa, a substantial proportion of squamous cell carcinomas (SCC) are observed related to the prevalence of infection with Schistosoma haematobium (bilharziasis). UBC has the highest per-patient lifetime cost for cancer in terms of healthcare expenditure compared to all other types of cancer. It is more frequent in men than in women and age is now widely accepted as the greatest single risk factor for developing UBC. The median age at diagnosis is 70 years. Cigarette smoking and specific occupational exposures, such as carcinogenic dyes for painters, are the main known causes of UBC.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

41

Hayat, M. A. Methods of Cancer Diagnosis, Therapy, and Prognosis: Ovarian Cancer, Renal Cancer, Urogenitary tract Cancer, Urinary Bladder Cancer, Cervical Uterine ... Leukemia, Multiple Myeloma and Sarcoma. Springer, 2016.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

42

Luo, Yongwen, Yi Zhang, Yu Xiao und Fang-Ming Deng, Hrsg. Molecular Biomarkers and Imaging Markers in the Prediction, Diagnosis, and Prognosis of Bladder Cancer. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-88976-629-1.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

43

Ma, Chao, Rong Fan und Antoni Ribas, Hrsg. Cancer Immunotherapy & Immuno-monitoring: Mechanism, Treatment, Diagnosis, and Emerging Tools. Frontiers SA Media, 2014. http://dx.doi.org/10.3389/978-2-88919-380-6.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

44

Persad, Raj, Hrsg. Advances in the Scientific Evaluation of Bladder Cancer and Molecular Basis for Diagnosis and Treatment. InTech, 2013. http://dx.doi.org/10.5772/56665.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

45

Biomarkers in breast cancer: Molecular diagnostics for predicting and monitoring therapeutic effect. Totowa, N.J: Humana Press, 2006.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

46

Breit, Alfred, P. Lukas und A. Heuck. Tumor Response Monitoring and Treatment Planning: Advanced Radiation Therapy. Springer, 2012.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

47

Breit, Alfred. Tumor Response Monitoring and Treatment Planning: Advanced Radiation Therapy. Springer-Verlag Telos, 1992.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

48

Breit, Alfred, P. Lukas, A. Heuck, P. Kneschaurek und M. Mayr. Tumor Response Monitoring and Treatment Planning: Advanced Radiation Therapy. Springer London, Limited, 2013.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

49

Diagnosis, Evaluation, and Treatment of Non-Muscle Invasive Bladder Cancer: An Update, an Issue of Urologic Clinics. Elsevier - Health Sciences Division, 2013.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

50

National Bowel Cancer Screening Program monitoring report, 2008: 7 August 2006-30 June 2008. Canberra: Australian Institute of Health and Welfare, 2007.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!